Edrophonium is a medicinal substance that stimulates the activity of skeletal muscles. It belongs to the group of parasympathomimetic drugs. Edrophonium is prescribed by injection to clarify the diagnosis of myasthenia gravis.
The mechanism of action of edrophonium is that it temporarily enhances the transmission of nerve impulses at neuromuscular synapses by inhibiting acetylcholinesterase, an enzyme that destroys the neurotransmitter acetylcholine.
Possible side effects when using edrophonium: nausea, vomiting, increased salivation, diarrhea, stomach pain.
Edrophonium is marketed under the trade name Tensilon. It allows you to quickly, within a few minutes, improve the contractility of muscles weakened by myasthenia and confirm the diagnosis of the disease.
Edrophonium is a drug that stimulates skeletal muscle activity and is used to diagnose myasthenia gravis (muscle weakness). However, like any other medicine, edrophonium may cause side effects such as nausea, vomiting, drooling, diarrhea and abdominal pain.
Edrophonium is a parasympathomimetic drug, meaning it stimulates the parasympathetic nervous system, which is responsible for muscle contraction and relaxation. This allows you to evaluate the condition of the muscles and determine whether the patient has myasthenia gravis.
The drug is administered intravenously or intramuscularly as injections. Typically the dosage is 0.5-1 mg per kg body weight, but can be increased to 2 mg per kg if necessary.
The side effects of edrophonium may be related to its effect on the parasympathetic nervous system. These may include nausea, vomiting, increased salivation and diarrhea. Abdominal pain may also occur, especially at high dosages.
Despite possible side effects, edrophonium remains one of the most effective drugs for diagnosing myasthenia gravis and treating muscle weakness. However, before starting treatment, it is necessary to conduct a thorough examination and evaluate the possible risks and benefits.
Edrophonum is a drug used to activate skeletal muscles in severe pseudoparalytic myasthenic dystrophy. It is often prescribed by injection to accurately diagnose pseudoparalythiasis, and is also used as a “booster” for other anticholinergic medications. Using edrophonium may cause side effects such as nausea, vomiting, increased salivation or diarrhea, and in rare cases, abdominal pain. Edrophonium may also cause allergic reactions or worsening muscle weakness. In such cases, you must immediately stop using it. Despite this, edrophonium is generally considered an effective drug in the treatment of pseudoparadithic rickets.